Skip to main content
Livermore
Livermore
ZHEN

Natixis Advisors, L.P.

SEC CIK
0001018331
Latest filing
Aug 14, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
19,495
Value
$1.11M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of BMRN by Natixis Advisors, L.P., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202619,495$1.11M<0.1%+5,878+43.2%AddedHolders
Q1 202613,617$769.0K<0.1%+13,617NewHolders
Q4 20250$00.0%−11,018−100.0%Sold outHolders
Q3 202511,018$597.0K<0.1%−14,212−56.3%ReducedHolders
Q2 202525,230$1.39M<0.1%−7,996−24.1%ReducedHolders
Q1 202533,226$2.35M<0.1%+13,488+68.3%AddedHolders
Q4 202419,738$1.30M<0.1%+19,738NewHolders
Q3 20240$00.0%−18,901−100.0%Sold outHolders
Q2 202418,901$1.56M<0.1%−36,548−65.9%ReducedHolders
Q1 202455,449$4.84M<0.1%−4,170−7.0%ReducedHolders
Q4 202359,619$5.75M<0.1%−248−0.4%ReducedHolders
Q3 202359,867$5.30M<0.1%+116+0.2%AddedHolders
Q2 202359,751$5.18M<0.1%−1,207−2.0%ReducedHolders
Q1 202360,958$5.93M<0.1%−1,387−2.2%ReducedHolders
Q4 202262,345$6.45M<0.1%−13,239−17.5%ReducedHolders
Q3 202275,584$6.41M<0.1%+7,171+10.5%AddedHolders
Q2 202268,413$5.67M<0.1%+8,047+13.3%AddedHolders
Q1 202260,366$4.65M<0.1%−4,016−6.2%ReducedHolders
Q4 202164,382$5.69M<0.1%+8,867+16.0%AddedHolders
Q3 202155,515$4.29M<0.1%+25,314+83.8%AddedHolders
Q2 202130,201$2.52M<0.1%+10,137+50.5%AddedHolders
Q1 202120,064$1.51M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.